EntryPoint Capital’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $307K | Sell |
89,570
-98,252
| -52% | -$337K | 0.15% | 265 |
|
|
2025
Q1 | $419K | Buy |
187,822
+19,140
| +11% | +$42.7K | 0.19% | 170 |
|
|
2024
Q4 | $494K | Buy |
168,682
+51,524
| +44% | +$151K | 0.21% | 110 |
|
|
2024
Q3 | $305K | Buy |
+117,158
| New | +$305K | 0.17% | 242 |
|
|
2024
Q2 | – | Sell |
-3,728
| Closed | -$16.9K | – | 824 |
|
|
2024
Q1 | $16.9K | Buy |
+3,728
| New | +$16.9K | 0.02% | 1141 |
|